Drugs / CZ10
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06708767 | Jan 2050 → Jan 2052 expected | — | Nextrast, Inc. | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CZ10 | “a novel intravenous CT contrast material (CZ10)” NCT06708767 ↗ |
| Modality | Diagnostic / imaging agent | “novel intravenous CT contrast material (CZ10)” NCT06708767 ↗ |
| Route | Intravenous | “intravenous CZ10 medical imaging contrast material” NCT06708767 ↗ |